KLOW
A quad-peptide combination of BPC-157, TB-500, GHK-Cu, and KPV targeting complementary angiogenic, cellular migration, extracellular matrix remodeling, and anti-inflammatory pathways in preclinical research. Premium Research Peptide.
$120.99
BUNDLE & SAVE
*Discount will be automatically applied in cart
Ships from the USA
Same or next business day
Damage protection
every order covered
Secure checkout
256-bit SSL
Certificate of analysis · lot KLO0001
Every lot, independently tested
This batch of KLOW was analysed by an independent third-party laboratory before release. Below is what the lab measured, exactly as reported.
- Lot
- KLO0001
- Labeled
- 80mg
- Measured
- 101.10 mg total
| Test | Method | Specification | Result | Status |
|---|---|---|---|---|
| Purity | HPLC-UV | ≥ 99.0 % | 99.80% | PASS |
| Net peptide content | HPLC | Report result | 101.10 mg total | REPORTED |
| Identity | LC-MS | Conforms | Confirmed | PASS |
| Appearance | Visual | Report result | Blue Lyophilized Powder | REPORTED |
Method: HPLC with UV detection coupled with mass spectrometry (LC-MS). Values shown are from the certificate for this batch. Your order ships with its own lot-specific report.
View full COA →Product specification
Compound data
Component Profiles
KPV Structure
Storage Requirements
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
